Cervix BT - 2016

Indications for combined intracavitary/interstitial

• •

middle/distal parametrial tumor extension unfavourable topography/unfavourable relation to the applicator (e.g. asymmetrical tumors) (depending on applicator position)

• • •

distal intravaginal tumor growth para-vaginal tumor growth

unfavourable topography of organs at risk (not predictable – correction within the frame of subsequent applications)